Use this instructional guide to review efficacy, dosing, and administration details, and to get information about integrating IMLYGIC® into your practice.
IMLYGIC® is shipped from select authorized specialty distributors—use this guide to find a qualified distributor. Also find information on ordering options, the order and delivery schedule and product storage.
Because of its special properties and storage requirements, IMLYGIC® is shipped on a fixed delivery schedule for coordination with patient scheduling. Download and print a copy of the schedule here for convenience.
Get some key product information, including packaging details, information on ordering IMLYGIC®, and storage and handling requirements.
The Prescribing Information provides all of the requirements for handling IMLYGIC®. This Checklist is not intended to serve as a replacement for the Prescribing Information.
The Lesion Tracking Sheet can help you document treatment of melanoma lesions.
Before using IMLYGIC® it is important to review the Prescribing Information. IMLYGIC® requires special storage conditions. Please see the Prescribing Information (section 2) for details on preparation and handling, including guidance on thawing and storage of IMLYGIC® vials.
Orders of IMLYGIC® are managed directly by Amgen. Please complete a Customer Registration Profile at the IMLYGIC® Customer Registration Page to ensure that Amgen has the information needed for processing your orders.
IMPORTANT SAFETY INFORMATION
IMLYGIC® is a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma recurrent after initial surgery.
Limitations of use: IMLYGIC® has not been shown to improve overall survival or have an effect on visceral metastases.